Related Experiment Video

Updated: Aug 15, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Prognosis in hypertensives with acute myocardial infarction

J Herlitz1, B W Karlson, A Richter

  • 1Department of Medicine I, Sahlgrenska Hospital, Gothenburg, Sweden.

Journal of Hypertension
|October 1, 1992
PubMed

Insights

Patients with a history of hypertension hospitalized for acute myocardial infarction face a poorer prognosis. These individuals have higher mortality and reinfarction rates within one year post-discharge compared to normotensive patients.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Acute Myocardial Infarction

Background:

  • Hypertension is frequently observed in patients with ischemic heart disease.
  • Understanding the impact of prior hypertension on acute myocardial infarction (AMI) prognosis is crucial for patient management.

Purpose of the Study:

  • To investigate the influence of a previous history of hypertension on the prognosis of patients hospitalized with acute myocardial infarction.

Main Methods:

  • A prospective study followed 917 patients hospitalized for AMI over 1 year.
  • Data collected included patient history, in-hospital outcomes, and post-discharge mortality and morbidity.

Main Results:

  • A history of hypertension was reported in 324 AMI patients, who also had higher rates of prior myocardial infarction, angina, heart failure, and diabetes.
  • While in-hospital mortality was similar, 1-year total mortality was significantly higher in hypertensive patients (35%) versus normotensive patients (25%).
  • Hypertension independently predicted death and reinfarction, which occurred twice as frequently in hypertensive patients.

Conclusions:

  • A history of hypertension is a significant indicator of poor prognosis in acute myocardial infarction patients.
  • Hypertensive patients face a one-third risk of death and a one-quarter risk of reinfarction within the first year following AMI.
Abstract

More Related Videos

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Histological Quantification of Chronic Myocardial Infarct in Rats09:45

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...